CatalystWireBeta

UK small-cap RNS · 22 May 2026

Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.

Sort: Newest · Largest companies
  1. 14:45
    Additional Sensor order
    Adds a $1.3M follow-on sensor order, beyond the $39.6M contract, from an affiliated organisation of the existing customer. Deliveries run 2026 to Q2 2027, and further orders are flagged.
    Transformational contract / build-out £1.0m · 1% of mcapoutlook positive +0.0% on the day
    Moved: New-generation sensor rollout and servicing: First sensors delivered, $5.7M paid → Additional $1.3M order received; more expected
  2. 13:45
    Bodycote BOY £1,541m
    Response to media speculation
    Apollo has made a conditional proposal at 885p cash plus the 16.1p final dividend, after several earlier proposals. The board is in discussions, but no firm offer exists yet.
    Takeover target first since Oct 2023 +19.0% on the day
    Moved: new: Possible offer for the company – Conditional proposal received; talks ongoing
  3. 13:16
    Holding(s) in Company Holding
  4. 12:06
    Holding(s) in Company Holding
  5. 10:11
    Result of Placing Fundraise
    Raises £5.5m at 15p, a 31.9% premium, with directors taking £2.15m, which adds funding after a going-concern uncertainty. It dilutes holders by about 8.9% and is not conditional on the CME sale or CLNs.
    Balance-sheet stress / refinancing £5.5m · 11% of mcapfirst since Oct 2023 +27.5% on the day
    Moved: Path to self-sustaining cashflows: Placing launched; CLN and CME sale pending → Placing completed; admission pending
  6. 07:02
    Proposed Placing to raise approximately £5.5m Fundraise
    Raises about £5.5m at a 31.9% premium to the last close, with directors subscribing about £2.15m. But the FY25 going-concern note flags material uncertainty, and the placing is unconditional on the CME sale or the CLNs.
    Disposal of a part (break-up) £5.5m · 11% of mcapoutlook positive, raised +27.5% on the day
    Moved: Path to self-sustaining cashflows: CLN conditional; equity raise planned; CME sale non-binding → Placing launched; CLN and CME sale pending · Sale of 49% Creo Medical SL stake: Non-binding agreement; due diligence pending → Non-binding agreement; completion targeted within three months
  7. 07:01
    FY25 Final Results Results
    The floor of FY26 revenue growth guidance rises from 40% to 50% (top end stays 60%), backed by c.60% Q1 growth. This goes beyond the April reaffirmation of the unchanged 40-60% range.
    Disposal of a part (break-up) in lineoutlook positive, raised +27.5% on the day
    Moved: Path to self-sustaining cashflows: Balance sheet support proposed via CME stake sale → CLN conditional; equity raise planned; CME sale non-binding · Sale of 49% Creo Medical SL stake: Non-binding LOI signed; due diligence pending → Non-binding agreement; due diligence pending
  8. 07:00
    Receipt of revised Requisition Notice
    Saba widens its requisition to remove all six NEDs and appoint six nominees, and its stake rises to about 21.12% from 18.21%. Board control is at stake during the new CEO's turnaround.
    Turnaround plan with targets −0.9% on the day
    Moved: Saba Capital board requisition: Requisition received; Board reviewing → Revised requisition received; Board reviewing · Fix, Accelerate and Scale turnaround: Board defends strategy against Saba requisition → Board defends strategy against widened Saba requisition
  9. 07:00
    Proposed Sale of 49% Interest in Creo Medical SL
    Non-binding LOI to sell the 49% stake in Creo Medical S.L. for cash at about carrying value would strengthen the balance sheet and fund growth, though it is subject to due diligence, financing and definitive documents.
    Disposal of a part (break-up) +27.5% on the day
    Moved: new: Sale of 49% Creo Medical SL stake – Non-binding LOI signed; due diligence pending · Path to self-sustaining cashflows: Revenue growing; cost cuts under way → Balance sheet support proposed via CME stake sale
  10. 07:00
    Tekcapital takes stake in geothermal AI firm
    Tekcapital Europe gets 51% of new AI/geothermal company Vesari for no cash, a capital-light entry. But the IP is unfiled patent applications from the Executive Chairman, who holds the other 49%, and the model is unproven.
    Project milestones first since Oct 2023 −0.8% on the day
    Moved: new: Vesari geothermal AI portfolio company – Formed; 51% held; patents not yet filed
  11. 07:00
    Final Results Results
    Audited FY2025 results show first LNG sales slipping to Q3 2026 and a c.£12.5m Sidi Moktar impairment, plus a $1.5m ONHYM guarantee claim, offset by funded Phase 1 and the Anoual extension.
    Legal & regulatory outlook positivefirst in 8 months −2.9% on the day
    Moved: Tendrara TE-5 Horst gas development: Wells and gathering system commissioned; power next → Commissioning; first gas early Q3 2026 · Bridging finance to first gas: Funding options under review → Operator-arranged ~$25m facility; Sound share ~$5m · Anoual M5 exploration well: Permits extended; firm well commitment → Permit extended to 7 Sept 2028
  12. 07:00
    Final Results Results
    Record revenue of £121.2m and underlying EBITDA of £6.4m, but statutory PBT fell to £0.9m from £2.2m and the audit opinion is qualified. The H1 update flags project delays in Labour Supply.
    Transformational contract / build-out £121.2m · 401% of mcapin lineoutlook mixed +9.4% on the day
    Moved: FY25 audit delay and suspension: Audit in final stages; deadline will be missed → Accounts published with qualified audit opinion; suspension lifting · Power and energy sector expansion: Added to Balfour Beatty power PSL → Lyons Power Services acquired October 2025
  13. 07:00
    Final Results Results
    IFRS profit fell to £5.7m from £27.9m and the final dividend was cut to 1.00p, but EPRA EPS doubled to 4.5p on development profits and a £17m capital return is proposed.
    Project milestones £333.0m · 157% of mcapoutlook positive +2.3% on the day
    Moved: 100 New Bridge Street forward sale: Practical completion achieved; sale completes 20 May → Sale completed 20 May 2026 (closed) · new: Return of capital from sale proceeds – Proposed; buyback to start shortly · London office development programme: Four schemes under construction → Two schemes due for completion in 2026
  14. 07:00
    Final Results Results
    Record FY2025 revenue and free cash flow, with the company debt free, but Runruno output fell 22.2% and FY2026 guidance was already cut to 40,000-48,000 oz as the mine nears end of life.
    Project milestones outlook mixed, loweredfirst in 8 months −4.9% on the day
    Moved: La India construction: 40% complete, ahead of schedule, mining concession renewed → About 50% complete, ahead of schedule · Runruno end of mine life: FY2026 guidance cut again; Dupax ruled out → FY2026 guidance cut; plant options evaluated
  15. 07:00
    Update on Disposals and a Return to Shareholders
    Confirms the PHFC sale completed on 28 Feb 2026 with £10.7m net proceeds, expected tax-free, and a further 40p special dividend, so most of the value unlocked goes back to shareholders.
    Disposal of a part (break-up) £10.7m · 67% of mcap +13.3% on the day
    Moved: Strategic options review: PHFC sold; proceeds use still to be decided → Proceeds use decided: 40p special dividend
  16. 07:00
    Update on the WMATA Contract
    WMATA has terminated Diamond's paratransit contract on 12 May 2026, after Diamond sued in January. Reciprocal litigation is now possible with an uncertain outcome, and the company cannot comment further.
    Legal & regulatory next step +0.9% on the day
    Moved: WMATA contract dispute: Onerous provision booked; legal action started → WMATA terminated contract 12 May; litigation ongoing
  17. 07:00
    Auction Results – Higher-Quality Emeralds Results
    Kagem higher-quality auction sold 99% by weight with strong top-tier pricing, but revenue and price per carat fell from Sep '25 and MRM ruby auctions are being scaled back on low production and weak demand.
    Project milestones outlook negative, lowered +0.0% on the day
    Moved: MRM second processing plant: Commissioning still delayed; H1 2026 challenging → Ruby production below expectations; June auction cut
  18. 07:00
    AGM Update: Formal Sale Process
    Sale process is still running and the company now reports credible interest from potential acquirers, which keeps a bid possible. There is still no offer or price, and no certainty of a deal.
    Moved: Formal Sale Process: Ongoing; no offer or price yet → Credible interest received; discussions ongoing

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note